{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["28(2)"],"submitter":["Rebolledo Del Toro M"],"funding":["Pontifical Xavierian University"],"pubmed_abstract":["Close and frequent follow-up of heart failure (HF) patients improves clinical outcomes. Mobile telemonitoring applications are advantageous alternatives due to their wide availability, portability, low cost, computing power, and interconnectivity. This study aims to evaluate the impact of telemonitoring apps on mortality, hospitalization, and quality of life (QoL) in HF patients. We conducted a registered (PROSPERO CRD42022299516) systematic review of randomized clinical trials (RCTs) evaluating mobile-based telemonitoring strategies in patients with HF, published between January 2000 and December 2021 in 4 databases (PubMed, EMBASE, BVSalud/LILACS, Cochrane Reviews). We assessed the risk of bias using the RoB2 tool. The outcome of interest was the effect on mortality, hospitalization risk"],"journal":["Heart failure reviews"],"pagination":["431-452"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9845822"],"repository":["biostudies-literature"],"pubmed_title":["Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis."],"pmcid":["PMC9845822"],"pubmed_authors":["Munoz Velandia OM","Garcia Pena AA","Herrera Leano NM","Fernandez Avila DG","Barahona-Correa JE","Rebolledo Del Toro M"],"additional_accession":[]},"is_claimable":false,"name":"Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis.","description":"Close and frequent follow-up of heart failure (HF) patients improves clinical outcomes. Mobile telemonitoring applications are advantageous alternatives due to their wide availability, portability, low cost, computing power, and interconnectivity. This study aims to evaluate the impact of telemonitoring apps on mortality, hospitalization, and quality of life (QoL) in HF patients. We conducted a registered (PROSPERO CRD42022299516) systematic review of randomized clinical trials (RCTs) evaluating mobile-based telemonitoring strategies in patients with HF, published between January 2000 and December 2021 in 4 databases (PubMed, EMBASE, BVSalud/LILACS, Cochrane Reviews). We assessed the risk of bias using the RoB2 tool. The outcome of interest was the effect on mortality, hospitalization risk","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Mar","modification":"2026-03-17T15:22:22.392Z","creation":"2025-04-06T01:07:20.23Z"},"accession":"S-EPMC9845822","cross_references":{"pubmed":["36652096"],"doi":["10.1007/s10741-022-10291-1"]}}